{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:09:49Z","timestamp":1783922989506,"version":"3.55.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with mental disorders are at increased risk of hepatitis C virus (HCV) infection, yet the prevalence of HCV among patients in Polish psychiatric ward remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional survey was conducted in Poland from 2021 to 2023 in psychiatric wards. Adults recently hospitalized with at least one current mental health condition were eligible and 12\u2013897 individuals were tested for anti HCV antibodies. Patients with confirmed active HCV infection (subsequent nucleic acid testing) were offered treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 12,897 individuals who constituted the sample, 64% were male, and the median age was 45 years (interquartile range: 35\u201358 years). Among those subjects, 226 patients (representing 1.8% of the total) exhibited a positive HCV antibody test result, and 172 of these patients had active HCV infection (the prevalence of 1.3%). Multivariate analysis identified five risk factors for HCV infection within the investigated population: intravenous drug use (odds ratio [OR] = 9.40; 95% confidence interval [CI]: 6.12\u201314.44; p&amp;lt;0.001), diagnosed and treated liver disease (OR\u00a0=\u00a06.17; 95% CI: 4.10\u20139.26; p &amp;lt; 0.001); blood transfusions prior to 1992 (OR\u00a0=\u00a02.61; 95% CI: 1.29\u20135.28; p=0.008), diagnosis of mental and behavioral disorders due to psychoactive substance abuse (OR\u00a0=\u00a01.97; 95% CI: 1.34\u20132.91; p=0.001) and previous incarceration (OR\u00a0=\u00a01.62; 95% CI: 1.08\u20132.43, p=0.018).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>High prevalence of HCV infection in patients with mental health disorders and specifically in patients who used intravenous drugs suggests the importance of screening for HCV in this vulnerable population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1835310","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:32:56Z","timestamp":1783920776000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and predictors of HCV infection among hospitalized psychiatric patients in Poland"],"prefix":"10.3389","volume":"17","author":[{"given":"Krzysztof","family":"Tomasiewicz","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Medical University of Lublin","place":["Lublin, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ga\u0142ecki","sequence":"additional","affiliation":[{"name":"Department of Adult Psychiatry, Medical University of Lodz","place":["L\u00f3d\u017a, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Jaroszewicz","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hepatology, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Opoka","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Medical University of Warsaw","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Paw\u0142owska","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hepatology, Faculty of Medicine, Nicolaus Copernicus University","place":["Toru\u0144, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Piekarska","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hepatology, Medical University of Lodz","place":["L\u00f3d\u017a, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Simon","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hepatology, Wroclaw Medical University","place":["Wroc\u0142aw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Zar\u0119bska-Michaluk","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Allergology, Jan Kochanowski University","place":["Kielce, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"W\u0142adysiuk","sequence":"additional","affiliation":[{"name":"Collegium Medicum, Jagiellonian University","place":["Krak\u00f3w, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Prycel","sequence":"additional","affiliation":[{"name":"Central and Eastern European Society of Technology Assessment in Health Care","place":["Krak\u00f3w, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0142awomir","family":"Ros","sequence":"additional","affiliation":[{"name":"Gilead Sciences Poland","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Obierzy\u0144ski","sequence":"additional","affiliation":[{"name":"Gilead Sciences Poland","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar","family":"Halota","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hepatology, Faculty of Medicine, Nicolaus Copernicus University","place":["Toru\u0144, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Flisiak","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hepatology, Medical University of Bialystok","place":["Bia\u0142ystok, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B2","unstructured":"Management of physical health conditions in adults with severe mental disorders\n          \n          \n          \n          2018"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(15)00357-0","article-title":"Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness: a systematic review and meta-analysis","volume":"3","author":"Hughes","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/livers4020013","article-title":"The epidemiology of chronic hepatitis C: Where we are now","volume":"4","author":"Stasi","year":"2024","journal-title":"Livers"},{"key":"B5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13011-020-00306-1","article-title":"Prevalence and high risk behaviours associated with HCV testing among people who inject drugs: a systematic review and meta-analysis","volume":"15","author":"Karimi","year":"2020","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100279","article-title":"Hepatitis C prevalences in the psychiatric setting: Cost-effectiveness of scaling-up screening and direct-acting antiviral therapy","volume":"3","author":"Girardin","year":"2021","journal-title":"JHEP Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/schizbullopen\/sgab058","article-title":"Hepatitis C screening among Medicaid patients with schizophrenia, 2002-2012","volume":"3","author":"Thomas","year":"2022","journal-title":"Schizophr Bull Open"},{"key":"B8","article-title":"Hepatitis C virus screening and linkage to care in mental health units: An opportunity for HCV elimination","volume":"50","author":"Fuentes","year":"2022","journal-title":"Actas Esp Psiquiatr"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/v13112249","article-title":"A review on extrahepatic manifestations of chronic hepatitis C virus infection and the impact of direct-acting antiviral therapy","volume":"13","author":"Mazzaro","year":"2021","journal-title":"Viruses"},{"key":"B10","unstructured":"Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i25.4085","article-title":"Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders","volume":"29","author":"Dybowska","year":"2023","journal-title":"World J Gastroenterol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5114\/ceh.2023.125957","article-title":"Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2023","volume":"9","author":"Tomasiewicz","year":"2023","journal-title":"Clin Exp Hepatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: Final update of the series\u2606","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J Hepatol"},{"key":"B14","unstructured":"19.3743 | Eliminer l\u2019h\u00e9patite. Inscription de la maladie dans un programme national de lutte contre les infections transmissibles sexuellement et par le sang | Objet | Le Parlement suisse"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1186\/s12889-024-18470-5","article-title":"Hepatitis C screening in Lithuania: first-year results and scenarios for achieving WHO elimination targets","volume":"24","author":"Petkevi\u010dien\u0117","year":"2024","journal-title":"BMC Public Health"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(24)01940-8","article-title":"Population-based hepatitis C screening in Lithuania: 18-month results of the program and scenarios for achieving WHO elimination targets","volume":"80","author":"Kupcinskas","year":"2024","journal-title":"J Hepatol"},{"key":"B17","unstructured":"Zdrowie i ochrona zdrowia w 2022 roku"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/v14030482","article-title":"HCV elimination in Central Europe with particular emphasis on microelimination in prisons","volume":"14","author":"Flisiak","year":"2022","journal-title":"Viruses"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.5114\/ceh.2020.94969","article-title":"Searching for the optimal population for hepatitis C virus screening in Poland","volume":"6","author":"Piekarska","year":"2020","journal-title":"Clin Exp Hepatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2022.06.005","article-title":"Prevalence of hepatitis C virus infection in patients with chronic mental disorders: The relevance of dual disorders","volume":"46","author":"Roncero","year":"2023","journal-title":"Gastroenterol Hepatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15569","article-title":"Low risk of viral hepatitis amongst patients with severe mental disorders","volume":"43","author":"Fern\u00e1ndez","year":"2023","journal-title":"Liver Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/imj.15604","article-title":"Hepatitis C virus in people with serious mental illness: an analysis of the care cascade at a tertiary health service with a pilot \u201cidentify and treat\u201d strategy","volume":"53","author":"Braude","year":"2023","journal-title":"Intern Med J"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13056","article-title":"Hepatitis C virus infection in Australian psychiatric inpatients: A multicenter study of seroprevalence, risk factors and treatment experience","volume":"26","author":"Ramachandran","year":"2019","journal-title":"J Viral Hepat"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13875","article-title":"Profile of patients with a positive HCV viral load in a large French psychiatric hospital (2019-2021): A case-control study","volume":"30","author":"Torres","year":"2023","journal-title":"J Viral Hepat"},{"key":"B25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.encep.2023.11.023","article-title":"Prevalence of hepatitis C, hepatitis B and HIV and their therapeutic management in a French public psychiatric hospital","volume":"51","author":"Icole","year":"2025","journal-title":"Encephale"},{"key":"B26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/liv.14283","article-title":"Direct-acting antiviral interactions with opioids, alcohol or illicit drugs of abuse in HCV-infected patients","volume":"40","author":"Ing Lorenzini","year":"2020","journal-title":"Liver Int"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1835310\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:32:57Z","timestamp":1783920777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1835310\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":26,"alternative-id":["10.3389\/fpsyt.2026.1835310"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1835310","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"article-number":"1835310"}}